Biomedical Engineering Reference
In-Depth Information
240. Pavan, B., Dalpiaz, A., Ciliberti, N., Biondi, C., Manfredini, S., Vertuani, S.,
2008, “Progress in drug delivery to the central nervous system by the prodrug
approach,” Molecules, 13, pp. 1035-1065.
241. Nair, B.G., Varghese, S.H., Nair, R., Yoshida, Y., Maekawa, T., Kumar, D.S.,
2011, “Nanotechnology platforms; an innovative approach to brain tumor
therapy,” Med. Chem., 7, pp. 488-503.
242. Collins, K.L., orringer, D.A., Patil, P.G., 2010, “Nanotechnology in
neurosurgery,” J. Nanotechnol. Eng. Med., 1, pp. 1-15.
243. Caffo, M., Caruso, G., Barresi, V., Pino, M.A., Venza, M., et al., 2012,
“Immunohistochemical study of CD68 and CR3/43 in astrocytic gliomas,” J.
Anal. Oncol., 1, pp. 42-49.
244. Raudino, G., Caffo, M., Caruso, G., Alafaci, C., Tomasello, F., 2011,
“Nanoparticle-based cerebral drug delivery systems and antiangiogenic
approach in gliomas treatment,” Rec. Pat. Nanotech., 5, pp. 239-244.
245. Wang, Y., Luang, L., 2012;“Multifunctional theranostic nanoparticles for brain
tumors,” Mol. Ther., 20, p. 1.
246. Im, S.A., Gomez-Manzano, C., Fueyo, J., et al., 1999, “Antiangiogenesis
treatment for gliomas: Transfer of antisense-vascular endothelial growth
factor inhibits tumor growth in vivo,” Cancer Res., 59, pp. 895-900.
247. Agemy, L., Friedmann-Morvinski, D., Kotamraju, V.R., Roth, L., Sugahara,
K.N., et al., 2011, “ Targeted nanoparticle enhanced proapoptotic peptide as
potential therapy for glioblastoma,” PNAS, 42, pp. 17450-17455.
248. Sawyer, A.J., Saucier-Sawyer, J.K., Booth, C.J., Liu, J., Patel, T., Piepmeier,
J.M., Saltzman, W.M., 2011, “Convection-enhanced delivery of camptothecin-
loaded polymer nanoparticles for treatment of intracranial tumors,” Drug.
Deliv. Transl. Res., 1, pp. 34-42.
249. Hadjipanayis, C.G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A.J.,
et al., 2010,“EGFRvIII antibody conjugated iron oxide nanoparticles for MRI
guided convection-enhanced delivery and targeted therapy of glioblastoma,”
Cancer Res., 70, pp. 6303-6312.
250. Kim, T., Jeong, Y., Jin, S., Pei, J., Jung, T., et al., 2011, “Preparation of polylactide-
co-glycolide nanoparticles incorporating celecoxib and their antitumor activity
against brain tumor cells,” Int. J. Nanomed., 6, pp. 2621-2631.
251. Lim, K.J., Bisht, S., Bar, E.E., Maitra, A., Eberhart, C.G., 2011, “A polymeric
nanoparticle formulation of curcumin inhibits growth, clonogenicity
and stem-like fraction in malignant brain tumors,” Cancer Biol. Ther., 11,
pp. 464-473.
252. Ding, H., Inoue, S., Ljubimov, A.V., Patil, R., Portilla-Arias, J., et al.,
2010, “Inhibition of brain tumor growth by intravenous poly(b-L-malic
acid) nanobioconjugate with pH-dependent drug release,” PNAS, 107,
pp. 18143-18148.
253. Jung, J., Solanki, A., Memoli, K.A., Kamei, K., Kim, H., et al., 2010, “Selective
inhibition of human brain tumor cell proliferation via multifunctional quantum
dot-based siRNA delivery,” Angew Chem. Int. Ed. Engl., 49, pp. 103-107.
254. Zhao, D., Alizadeh, D., Zhang, L., Liu, W., Farrukh, O., et al., 2011, “Carbon
nanotubes enhance CpG uptake and potentiate antiglioma immunity,” Clin.
Cancer Res., 17, pp. 771-782.
